Mannkind (MNKD) Current Deferred Tax Assets (2011 - 2012)

Mannkind's (MNKD) quarterly Current Deferred Tax Assets came in at $784.6 million in Q4 2012, up 9.25% year-on-year from $718.2 million in Q1 2012, and up 9.25% on a QoQ basis from $718.2 million in Q4 2011.

Mannkind (MNKD) Current Deferred Tax Assets (2011 - 2012) Analysis & Trends

Mannkind (MNKD) has 2 years of Current Deferred Tax Assets data on file, last reported at $784.6 million in Q4 2012.

  • On a quarterly basis, Current Deferred Tax Assets rose 9.25% year-over-year to $784.6 million in Q4 2012; TTM through Dec 2012 was $784.6 million, a 9.25% increase from a year earlier, with the FY2012 full-year figure at $784.6 million, up 9.25% from the prior year.
  • Current Deferred Tax Assets for Q4 2012 stood at $784.6 million, up from $718.2 million in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for MNKD reached as high as $784.6 million in Q4 2012 and fell as low as $718.2 million in Q4 2011.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mannkind 1.20 Bn 1.07 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2012 784.60 Mn
Dec 31, 2012 784.60 Mn
Dec 31, 2011 718.20 Mn
Dec 31, 2011 718.20 Mn